SNWV logo

SANUWAVE HEALTH INC

SNWVNASDAQ
πŸ† #4535 by market capUS Equity
$4.73β–² $0.10 (+2.16%)
Market closed Β· at close
πŸ””
Track SNWV
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 2.2%
7dβ–² 0.4%
14dβ–² 9.2%
30dβ–Ό 0.4%
ytdβ–Ό 84.3%
1yβ–Ό 87.3%
🏦Market Cap
$41M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+35.0%
High Growth
πŸ“ŠGross Margin
75.2%
High
πŸ’΅FCF Margin
14.1%
Healthy
βš–οΈP/S Ratio
0.9x
Cheap
Otter Score
60
Fair

Trading Snapshot

Day Range
$4.68 – $4.77
52-Week Range
$3.92 – $40.87
Volume
$3.04B
Avg Volume
$2.05B
Shares Outstanding
8.6M
Next Earnings
Dec 15, 2026

Fundamentals Snapshot

Annual Revenue
$44M
Last Q Revenue
$12M
P/E Ratio
2.8
P/S Ratio
0.9x
EPS (TTM)
$1.66
Dividend Yield
0.00%

Why Investors Own SNWV

  • βœ“High-growth profile β€” revenue up +1.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 28% gross margin and 7% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SNWV logo

SANUWAVE HEALTH INC

SNWV
Financial Trends
Revenue (TTM)The total money the company brought in from sales, before subtracting any costs.
$44Mβ–² +5.9% YoY
Gross Margin (TTM)Of every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
28.4%β–Ό βˆ’0.3% YoY
Operating Income (TTM)Profit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$5Mβ–² +5.9% YoY
Free Cash Flow (TTM)Cash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$3Mβ–² +5.9% YoY
StockOtter Β· stockotter.space

About SANUWAVE HEALTH INC

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Ratings

β“˜
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates